Your browser doesn't support javascript.
loading
Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study.
Hannawi, Suad; Zhang, Rong-Rong; Abuquta, Alaa; Safeldin, Linda; Hassan, Aala; Alamadi, Ahmad; Hossain, Tasmiah; Mostafa, Mohamed; Ghoneim, Yasser; Solo, Jennifer; Zheng, Hong-Xia; Wu, Ding-Feng; Yu, Dan-Dan; Yuan, Jia-Cheng; Zhao, Di; Lin, Rui; Ying, Bo; Qin, Cheng-Feng.
Affiliation
  • Hannawi S; Internal Medicine Department, Al Kuwait-Dubai Hospital, Emirates Health Services (EHS), Ministry of Health and Prevention, Dubai, United Arab Emirates.
  • Zhang RR; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing, China.
  • Abuquta A; Accident and Emergency Department, Al Kuwait-Dubai Hospital, EHS, Ministry of Health and Prevention, Dubai, United Arab Emirates.
  • Safeldin L; General Surgery Department, Al Kuwait-Dubai Hospital, EHS, Ministry of Health and Prevention, Dubai, United Arab Emirates.
  • Hassan A; General Surgery Department, Al Kuwait-Dubai Hospital, EHS, Ministry of Health and Prevention, Dubai, United Arab Emirates.
  • Alamadi A; General Surgery Department, Al Kuwait-Dubai Hospital, EHS, Ministry of Health and Prevention, Dubai, United Arab Emirates.
  • Hossain T; General Surgery Department, Al Kuwait-Dubai Hospital, EHS, Ministry of Health and Prevention, Dubai, United Arab Emirates.
  • Mostafa M; PDC FZ-LLC, Contract Research Organization, Dubai, United Arab Emirates.
  • Ghoneim Y; PDC FZ-LLC, Contract Research Organization, Dubai, United Arab Emirates.
  • Solo J; PDC FZ-LLC, Contract Research Organization, Dubai, United Arab Emirates.
  • Zheng HX; Abogen Biosciences, Suzhou Abogen Biosciences Co., Ltd., Suzhou, China.
  • Wu DF; Abogen Biosciences, Suzhou Abogen Biosciences Co., Ltd., Suzhou, China.
  • Yu DD; Abogen Biosciences, Suzhou Abogen Biosciences Co., Ltd., Suzhou, China.
  • Yuan JC; Abogen Biosciences, Suzhou Abogen Biosciences Co., Ltd., Suzhou, China.
  • Zhao D; Abogen Biosciences, Suzhou Abogen Biosciences Co., Ltd., Suzhou, China.
  • Lin R; Abogen Biosciences, Suzhou Abogen Biosciences Co., Ltd., Suzhou, China.
  • Ying B; Abogen Biosciences, Suzhou Abogen Biosciences Co., Ltd., Suzhou, China.
  • Qin CF; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing, China.
Clin Transl Med ; 13(8): e1387, 2023 08.
Article in En | MEDLINE | ID: mdl-37612802
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Adult / Humans Language: En Journal: Clin Transl Med Year: 2023 Document type: Article Affiliation country: Emiratos Árabes Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Adult / Humans Language: En Journal: Clin Transl Med Year: 2023 Document type: Article Affiliation country: Emiratos Árabes Unidos Country of publication: Estados Unidos